Rocket Lab Shares Slip as Neutron Delays Overshadow Electron Progress

what happened

Rocket Lab (RKLB) shares were down more than 1% late Monday overnight, even after the company provided an update on Electron. Retail traders remained focused on delays affecting the medium-lift Neutron rocket. The stock finished Monday at $65.71, a 3.67% decline, following an 8% drop last week that marked its weakest weekly performance since late August.

In a post on X, Rocket Lab said Electron is still the world’s most frequently launched dedicated small-lift rocket. It also outlined the next three flights as the program approaches its 100th mission. ‘We’re Not Hawking Around’ is planned for no earlier than Oct.21 from Launch Complex 1 in New Zealand, carrying three HawkEye 360 satellites to low Earth orbit. The two subsequent iQPS missions for the Japanese satellite operator, ‘The Sea God Surveys’ and ‘The Mountain God Rises,’ are scheduled for no earlier than Nov. 4 and Nov. 10.

The announcement followed Electron’s 97th successful flight late last month, which placed a Synspective synthetic aperture radar satellite in orbit. The rocket had completed 18 missions this year through that flight. Last month, Rocket Lab signed a multi-year contract covering 20 Synspective satellites from 2028 through 2031. The agreement is Electron’s biggest commercial deal so far, taking Synspective’s total contracted Rocket Lab launches to 47 and lifting the company’s launch backlog above 100 missions.

Electron’s active schedule stands in contrast to the questions surrounding Neutron. Rocket Lab said in August that manufacturing of Neutron’s first-stage tank was still tracking toward delivery to the launch pad in the fourth quarter. It cautioned, however, that the time available for a year-end launch was shrinking because qualification work and other key tests had yet to be completed. The development effort had already suffered a setback in January, when a Stage 1 tank ruptured during a hydrostatic pressure test. Rocket Lab said another tank was being built and that work would proceed while the test findings were reviewed.

Second-quarter revenue reached a company record of $234 million, up 62% from the prior year, while the order backlog also set a record at $2.36 billion. Rocket Lab’s outlook for third-quarter revenue was $250 million to $265 million. Cash flow after operating and investment activity was approximately negative $110 million in Q2, reflecting spending on Neutron, infrastructure, and research and development.

Stocktwits data showed a 1,470% jump in RKLB message volume over 24 hours, with retail sentiment moving to ‘bearish’ from ‘neutral’ the previous day. One user said Neutron’s debut flight was still being pushed back and argued that dilution and ongoing losses weighed on the company, while the stock already reflected upbeat expectations for Neutron and Iridium. Another user wrote: “Another day, another dollar… except Rocket Lab keeps taking the dollar instead of making it!” A separate post said $58 “is a real possibility”, and another called it “just another down day”. Some participants were more positive: one described RKLB as “the most undervalued stock in the market”, while others said they were buying during declines. RKLB is down 6% year-to-date.

why it matters

The market is balancing Electron’s established launch cadence and growing backlog against the timing, testing requirements, and cash demands of the Neutron program, with retail sentiment turning more defensive.

instruments